Mood and Anxiety Disorders Overview
MCAT trap: Misclassifies OCD as an anxiety disorder rather than its own DSM-5 category. DSM-5 moved OCD into its own category — Obsessive-Compulsive and Related Disorders — separate from anxiety disorders.
Mood and anxiety disorders are a core chunk of the Individual Influences on Behavior section. The MCAT tests this material at multiple levels: straight recall of diagnostic criteria, mechanism questions about neurotransmitter systems, and — most importantly — passage vignettes where you have to match a patient description to a specific disorder or predict a treatment. The breadth here is the challenge. You're expected to distinguish between MDD and persistent depressive disorder, know why bipolar I and II aren't just 'severe vs. mild,' and correctly place OCD and PTSD in their proper DSM-5 categories — not the outdated anxiety disorder bucket where students habitually dump them.
The neurobiology angle is equally important. The monoamine hypothesis ties low serotonin, norepinephrine, and dopamine to depression. The HPA axis — chronically elevated cortisol damaging the hippocampus — connects stress biology to mood pathology. Anxiety disorders involve hyperactivation of the fear circuit, especially the amygdala. These mechanisms directly predict pharmacology: SSRIs, SNRIs, and benzodiazepines all have specific NT targets, and the MCAT will ask you to connect mechanism to drug class.
The biggest pitfall is overconfidence on definitions you half-remember. Students consistently misclassify OCD and PTSD as anxiety disorders because that's how older textbooks framed them. DSM-5 separated both into distinct categories, and the exam will absolutely exploit that. Similarly, Bipolar II trips people up because 'II' reads as 'less severe' — but the real distinction is hypomania versus full mania, not a simple severity ranking. Lock down these distinctions before moving to pharmacology.
Common misconceptions
What the exam tests
- Recognize the core diagnostic features that distinguish mood disorders (MDD, persistent depressive disorder, bipolar I, bipolar II) from anxiety disorders (GAD, panic disorder, specific phobia) and from OCD and PTSD, which now occupy their own separate DSM-5 categories.
- Explain the monoamine hypothesis of depression — how deficits in serotonin, norepinephrine, and dopamine contribute to depressive symptoms — and describe how HPA axis dysregulation and fear circuit hyperactivation (amygdala) relate to mood and anxiety pathology respectively.
- Read a clinical vignette and correctly identify the specific disorder based on symptom pattern, duration criteria, and distinguishing features (e.g., hypomania vs. mania, obsessions + compulsions vs. generalized worry, trauma trigger vs. unprovoked panic).
- Connect drug classes to their neurotransmitter mechanisms: SSRIs and SNRIs block reuptake transporters; benzodiazepines potentiate GABA-A; lithium stabilizes mood via second-messenger interference — and map these to the disorders they treat.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →